DHA to award Bridge Contract for Surge Operations & Analytics Support in support of MHS COVID-19 Response to Accenture

Notice ID: HT9402-21-RFI-0099

“The Government intends to issue a sole-source bridge contract to extend the MHS COVID 19 Response – MEDLOG Support, to Accenture Federal Services, LLC, in accordance with Federal Acquisition Regulation (FAR) 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. The contract period of performance will be from April 3, 2021, through October 4, 2021 with an option to extend for an additional 6 months depending on what the need of the government is at the end of the base period. The twelve (12) month bridge to extend performance is critical to ensure continued support to the DHA by continuing to meet critical requirements and prevent a gap in service which would affect data acquisition and distribution to all government agencies…”

“The intent is to obtain a six month contract, with an option for up to an additional six months, as a bridge to the end state when the program matures, COVID demand decreases and it can be internally supported.  The current workload remains constant due to COVID-19 virus variance, personal protective equipment management and continued demand for MEDLOG dashboard data across the DHA Headquarters.  Continuation of this contract provides a bridge to the end state at program maturity and decreased COVID demands, enabling DHA MEDLOG to develop steady state management, while maintaining COVID-19 data analytics, dashboards and decision support tools.”

“As stated above, the Government anticipates an end state in the response to the COVID-19 Pandemic with the rollout of the vaccines; however, due to the unpredictable nature of this novel virus and the ad hoc needs for data science architecture, manipulation and data delivery, the Government is seeking information on contractor interest and industry best practices in support of future Surge Operations & Analytics Support…”

Read more here.



Please enter your comment!
Please enter your name here